KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Net Cash Flow: 2019-2024

Historic Net Cash Flow for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to $124.2 million.

  • Hims & Hers Health's Net Cash Flow fell 2258.26% to -$777.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.1 million, marking a year-over-year increase of 67.72%. This contributed to the annual value of $124.2 million for FY2024, which is 148.90% up from last year.
  • As of FY2024, Hims & Hers Health's Net Cash Flow stood at $124.2 million, which was up 148.90% from $49.9 million recorded in FY2023.
  • Over the past 5 years, Hims & Hers Health's Net Cash Flow peaked at $124.2 million during FY2024, and registered a low of -$25.0 million during FY2022.
  • Over the past 3 years, Hims & Hers Health's median Net Cash Flow value was $49.9 million (recorded in 2023), while the average stood at $49.7 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 697.61% in 2021, then tumbled by 156.26% in 2022.
  • Hims & Hers Health's Net Cash Flow (Yearly) stood at $5.6 million in 2020, then surged by 697.61% to $44.4 million in 2021, then plummeted by 156.26% to -$25.0 million in 2022, then skyrocketed by 299.94% to $49.9 million in 2023, then surged by 148.90% to $124.2 million in 2024.